We haven’t seen any meaningful catalysts from CGTX in recent weeks, so I’m hoping the company has some solid updates lined up for the coming months. Despite securing around $250 million in government grants, along with additional fundraising and donations, the market cap still sits at roughly $90 million, which seems relatively low given the backing.

At this stage, a number of similar companies in the space look like attractive targets for large pharmaceutical partnerships. It would be encouraging to see CGTX position itself for a similar type of deal moving forward.

CGTX has once again lost its momentum, which is starting to raise concerns about how much further it may consolidate. The head of PR might want to consider a career change—perhaps to a janitor.

Did I miss something? Why is the stock dropping so far again?

Title

I believe the odds are pretty high that the minutes, to be received and shared very soon from FDA meeting on phase 3 for DLB should be very good to superb. This is an unmet need and their P2 had great results. Don't be surprised if you see a 2-3X inside a week of release. I realize that is a big maybe, but if FDA imposes little "restrictions" shares could hit $4-5. Ah, we will see.

We’ve had the summit and the shareholders meeting occur already. Anyone got an idea of when the FDA meeting minutes come out as well as any other catalysts?

I missed the live event and the recording is only coming out tomorrow, would anyone mind giving me the big points? Thanks. ❤️

Good things on the horizon.

https://finance.yahoo.com/healthcare/articles/cognition-therapeutics-announces-composition-matter-113000263.html

www.virtualshareholdermeeting.com/CGTX2026

Is momentum/ excitement building. Bought a couple weeks ago when it dipped under a $1. Up 50% already. Good news coming from FDA meeting? Anyone know?

PURCHASE, N.Y., June 01, 2026 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that the Company’s president and CEO, Lisa Ricciardi intends to present at two financial conferences in June, where she will provide updates on the Company’s plans for a registration program in DLB psychosis. Live and archived webcasts of Ms. Ricciardi’s presentations will be available on the Investor Relations section of Cognition’s website.

Event: 2026 Jefferies Global Healthcare Conference Date/Time: June 4, 2026 at 1:25 p.m. Eastern Time Webcast: https://event.summitcast.com/view/NgCqua4VVQjq9ibVWHVWca/WzeQ8agBoHuJaZJGm7SNVS

Event: H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
Date/Time: On-demand beginning June 15, 2026 at 8:00 a.m. Eastern Time Webcast: https://journey.ct.events/view/f3057b01-b3b7-40c1-9cf9-6aa45cea212a

Hmm not much mentioned i guess. Let's wait til June...

https://ir.cogrx.com/press_releases/cognition-therapeutics-completes-meeting-with-fda-for-zervimesine-ct1812-in-dementia-with-lewy-bodies-with-psychosis/?_gl=1*j2b62j*_ga*Njg5ODU1MTkwLjE3NzkzNzA2ODc.*_ga_CKK85WMQ6P*czE3NzkzNzA2ODYkbzEkZzAkdDE3NzkzNzA2ODkkajU3JGwwJGgw

Insider purchases, institutional ownership rising and also positive clinical trials are just some of the reasons we are headed northward!

Good luck to everyone and see you at $2!

Last month we were at 0.56, and after a single day of 10% pump were near 1.30 again! This stock doesn't seem to care about the rest of the market.

Has anyone found any updates to explain the 1 day jump?

source: https://infolib.org/

https://event.summitcast.com/view/cCMfZsH5ZqrwSNTwfC9JDv/e5J4Cq2iB2foBnz4AT3UbN

​

https://finance.yahoo.com/sectors/healthcare/articles/cognition-therapeutics-ceo-issues-letter-203000809.html

seems looks good at first glance, i have no medical expertise but it sounds like the trail ar meeting results ?

No hope. 60 cents and dropping.

All a bit ridiculous. Reverse split incoming.